These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 21273015)

  • 21. Activation and overexpression of the aryl hydrocarbon receptor contribute to cutaneous squamous cell carcinomas: an immunohistochemical study.
    Pan ZY; Chen J; Wu Q; Hu TT; Lu L; Ju Q
    Diagn Pathol; 2018 Aug; 13(1):59. PubMed ID: 30144817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical research of endoscopic grading of adenoid in pediatric otitis media with effusion].
    Nie M
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Oct; 26(19):904-5. PubMed ID: 23285960
    [No Abstract]   [Full Text] [Related]  

  • 23. Aryl Hydrocarbon Receptor in Post-Mortem Hippocampus and in Serum from Young, Elder, and Alzheimer's Patients.
    Ramos-García NA; Orozco-Ibarra M; Estudillo E; Elizondo G; Gómez Apo E; Chávez Macías LG; Sosa-Ortiz AL; Torres-Ramos MA
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32183254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The aryl hydrocarbon receptor, a molecular link between diet and immunity].
    Vonarbourg C
    Med Sci (Paris); 2012 Mar; 28(3):255-8. PubMed ID: 22480645
    [No Abstract]   [Full Text] [Related]  

  • 25. Aryl Hydrocarbon Receptor Repressor Methylation: A Link Between Smoking and Atherosclerosis.
    Cole JW; Xu H
    Circ Cardiovasc Genet; 2015 Oct; 8(5):640-2. PubMed ID: 26487726
    [No Abstract]   [Full Text] [Related]  

  • 26. The Yin and Yang of Arnt2 in Activity-Dependent Transcription.
    Okur Z; Scheiffele P
    Neuron; 2019 Apr; 102(2):270-272. PubMed ID: 30998895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. AHR: making the keratinocytes thick skinned.
    Colonna M
    Immunity; 2014 Jun; 40(6):863-4. PubMed ID: 24950209
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanisms of PAS Domain Signalling, from Sensing Varied Small Molecules and Peptides to Approved Pharmaceuticals and Use in Optogenetics.
    Khorasanizadeh S; Gardner KH
    J Mol Biol; 2024 Feb; 436(3):168457. PubMed ID: 38278435
    [No Abstract]   [Full Text] [Related]  

  • 29. [Advances on aryl hydrocarbon receptor in intestinal function and diseases].
    Na RN; Duan XY; Chen P
    Zhonghua Nei Ke Za Zhi; 2024 Mar; 63(3):296-302. PubMed ID: 38448364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aryl-hydrocarbon receptor agonist: A novel topical therapeutic approach for inflammatory skin diseases.
    Aoki V; Orfali RL
    J Eur Acad Dermatol Venereol; 2023 Jun; 37(6):1093-1094. PubMed ID: 37171290
    [No Abstract]   [Full Text] [Related]  

  • 31. Reply to: Pelargonidin and its glycosides as dietary chemopreventives attenuating inflammatory bowel disease symptoms through the aryl hydrocarbon receptor.
    Ghattamaneni NKR; Sharma A; Panchal SK; Brown L
    Eur J Nutr; 2020 Dec; 59(8):3865-3866. PubMed ID: 32648018
    [No Abstract]   [Full Text] [Related]  

  • 32. A molecular study of aryl hydrocarbon receptor activation in COVID 19 associated cognitive impairment - Correspondence.
    Singh Y; Singh SK; Dua K; Gupta G
    Int J Surg; 2022 Sep; 105():106895. PubMed ID: 36096293
    [No Abstract]   [Full Text] [Related]  

  • 33. The mode of action of tapinarof may not only depend on the activation of cutaneous aryl hydrocarbon receptor signaling but also on its antimicrobial activity.
    Haarmann-Stemmann T; Sutter TR; Krutmann J; Esser C
    J Am Acad Dermatol; 2021 Jul; 85(1):e33-e34. PubMed ID: 33677003
    [No Abstract]   [Full Text] [Related]  

  • 34. Expression of Concern: Downregulated brain and muscle aryl hydrocarbon receptor nuclear translocator-like protein-1 inhibits osteogenesis of BMSCs through p53 in type 2 diabetes mellitus.
    Mao X; Li X; Hu W; Hao S; Yuan Y; Guan L; Guo B
    Biol Open; 2020 Oct; 9(10):. PubMed ID: 33020142
    [No Abstract]   [Full Text] [Related]  

  • 35. Retraction: Downregulated brain and muscle aryl hydrocarbon receptor nuclear translocator-like protein-1 inhibits osteogenesis of BMSCs through p53 in type 2 diabetes mellitus.
    Mao X; Li X; Hu W; Hao S; Yuan Y; Guan L; Guo B
    Biol Open; 2022 Jun; 11(6):. PubMed ID: 35762673
    [No Abstract]   [Full Text] [Related]  

  • 36. Corrigendum to "Development and characterization of monoclonal antibodies against human aryl hydrocarbon receptor" [J. Environ. Sci. 39 (2016) 165-174].
    Tian W; Pei X; Xie HQ; Xu SL; Tian J; Hu Q; Xu H; Chen Y; Fu H; Cao Z; Zhao B
    J Environ Sci (China); 2016 Aug; 46():259-260. PubMed ID: 27521958
    [No Abstract]   [Full Text] [Related]  

  • 37. Erratum to: Role of the aryl hydrocarbon receptor in carcinogenesis and potential as an anti-cancer drug target.
    Kolluri SK; Jin UH; Safe S
    Arch Toxicol; 2017 Sep; 91(9):3209. PubMed ID: 28695231
    [No Abstract]   [Full Text] [Related]  

  • 38. Aryl hydrocarbon receptor activity may serve as a surrogate marker for MS disease activity.
    Sabatino JJ; Zamvil SS
    Neurol Neuroimmunol Neuroinflamm; 2017 Jul; 4(4):e366. PubMed ID: 28642890
    [No Abstract]   [Full Text] [Related]  

  • 39. Correction to "Antagonism of Aryl Hydrocarbon Receptor Signaling by 6, 2',4'-Trimethoxyflavone".
    J Pharmacol Exp Ther; 2018 Nov; 367(2):291. PubMed ID: 30305307
    [No Abstract]   [Full Text] [Related]  

  • 40. Autoimmune disease: Aryl hydrocarbon receptor suppresses inflammation.
    Crunkhorn S
    Nat Rev Drug Discov; 2018 Jun; 17(7):470. PubMed ID: 29950706
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.